Justin A Renz - Net Worth and Insider Trading
Justin A Renz Net Worth
The estimated net worth of Justin A Renz is at least $2 Million dollars as of 2024-04-26. Justin A Renz is the CFO of Ardelyx Inc and owns about 304,835 shares of Ardelyx Inc (ARDX) stock worth over $2 Million. Justin A Renz is also the EVP, CFO & Treasurer of Karyopharm Therapeutics Inc and owns about 19,173 shares of Karyopharm Therapeutics Inc (KPTI) stock worth over $20,323. Details can be seen in Justin A Renz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Justin A Renz has not made any transactions after 2024-02-20 and currently still holds the listed stock(s).
Transaction Summary of Justin A Renz
Justin A Renz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Justin A Renz owns 3 companies in total, including Ardelyx Inc (ARDX) , Karyopharm Therapeutics Inc (KPTI) , and EPIRUS Biopharmaceuticals Inc (EPRSQ) .
Click here to see the complete history of Justin A Renz’s form 4 insider trades.
Insider Ownership Summary of Justin A Renz
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARDX | Ardelyx Inc | 2024-02-20 | Chief Financial Officer |
KPTI | Karyopharm Therapeutics Inc | 2016-11-09 | EVP & Chief Financial Officer |
EPRSQ | EPIRUS Biopharmaceuticals Inc | 2014-02-10 | EVP & CFO & Treasurer |
Justin A Renz Latest Holdings Summary
Justin A Renz currently owns a total of 2 stocks. Among these stocks, Justin A Renz owns 304,835 shares of Ardelyx Inc (ARDX) as of February 20, 2024, with a value of $2 Million and a weighting of 98.95%. Justin A Renz also owns 19,173 shares of Karyopharm Therapeutics Inc (KPTI) as of November 9, 2016, with a value of $20,323 and a weighting of 1.05%.
Latest Holdings of Justin A Renz
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARDX | Ardelyx Inc | 2024-02-20 | 304,835 | 6.31 | 1,923,509 |
KPTI | Karyopharm Therapeutics Inc | 2016-11-09 | 19,173 | 1.06 | 20,323 |
Holding Weightings of Justin A Renz
Justin A Renz Form 4 Trading Tracker
According to the SEC Form 4 filings, Justin A Renz has made a total of 17 transactions in Ardelyx Inc (ARDX) over the past 5 years, including 1 buys and 16 sells. The most-recent trade in Ardelyx Inc is the sale of 5,341 shares on February 20, 2024, which brought Justin A Renz around $46,734.
According to the SEC Form 4 filings, Justin A Renz has made a total of 0 transactions in Karyopharm Therapeutics Inc (KPTI) over the past 5 years. The most-recent trade in Karyopharm Therapeutics Inc is the sale of 4,342 shares on November 9, 2016, which brought Justin A Renz around $35,561.
Insider Trading History of Justin A Renz
- 1
Justin A Renz Trading Performance
GuruFocus tracks the stock performance after each of Justin A Renz's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Justin A Renz is 34.93%. GuruFocus also compares Justin A Renz's trading performance to market benchmark return within the same time period. The performance of stocks bought by Justin A Renz within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Justin A Renz's insider trading performs compared to the benchmark.
Performance of Justin A Renz
Average Return
139.94%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 12.04 | 34.93 | 121.42 | 139.94 | -34.01 | -24.75 |
Relative Return to S&P 500(%) | 15.71 | 33.15 | 123.07 | 132.81 | -40.94 | -32.44 |
Justin A Renz Ownership Network
Ownership Network List of Justin A Renz
Ownership Network Relation of Justin A Renz
Justin A Renz Owned Company Details
What does Ardelyx Inc do?
Who are the key executives at Ardelyx Inc?
Justin A Renz is the Chief Financial Officer of Ardelyx Inc. Other key executives at Ardelyx Inc include director & President & CEO Michael Raab , See Remarks Elizabeth A Grammer , and Chief Development Officer David P. Rosenbaum .
Ardelyx Inc (ARDX) Insider Trades Summary
Over the past 18 months, Justin A Renz made 7 insider transaction in Ardelyx Inc (ARDX) with a net sale of 243,914. Other recent insider transactions involving Ardelyx Inc (ARDX) include a net sale of 129,101 shares made by David P. Rosenbaum , a net sale of 151,748 shares made by Elizabeth A Grammer , and a net sale of 85,747 shares made by Michael Raab .
In summary, during the past 3 months, insiders sold 174,646 shares of Ardelyx Inc (ARDX) in total and bought 0 shares, with a net sale of 174,646 shares. During the past 18 months, 762,466 shares of Ardelyx Inc (ARDX) were sold and 567,000 shares were bought by its insiders, resulting in a net sale of 195,466 shares.
Ardelyx Inc (ARDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ardelyx Inc Insider Transactions
Justin A Renz Mailing Address
Above is the net worth, insider trading, and ownership report for Justin A Renz. You might contact Justin A Renz via mailing address: C/o Karyopharm Therapeutics Inc., 85 Wells Avenue, Second Floor, Newton Ma 02459.